T-Guard as Treatment for Steroid Refractory Acute GVHD

Condition:   Steroid-Refractory Acute Graft Versus Host Disease Intervention:   Drug: T-Guard Sponsors:   Xenikos;   National Heart, Lung, and Blood Institute (NHLBI);   Blood and Marrow Transplant Clinical Trials Network;   National Cancer Institute (NCI);   National Marrow Donor Program Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials